BCAX three-lens brief
Evidence-based stock research on BCAX. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Moved -2.28% yesterday. · Trading >3% below the 50-day MA — short-term weakness.
- Moved -2.28% yesterday.
- Trading >3% below the 50-day MA — short-term weakness.
- Underperforming SPY by 14.7pp over 30 days.
- Currently unprofitable on a trailing basis — no P/E multiple available.
- Analyst mean target $34.54 — 50% above current (13 analysts).
BCAX closed at $23.10 (-2.28%) as of 2026-09-11. Market cap: $1.53B. Price is below the 50-day MA and above the 200-day MA. Positives: analyst mean target $34.54 — 50% above current (13 analysts).. Concerns: moved -2.28% yesterday.; trading >3% below the 50-day MA — short-term weakness.. Last quarter: net income -$55.44M, free cash flow -$76.95M.
Why three lenses on BCAX, not one.
A single reasoning model has blind spots it doesn’t know about. We examine BCAXacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/BCAX" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath BCAX brief"></iframe>